Future therapies for AML: bispecifics and small molecule inhibitors

With the recent maturation of novel therapies for acute myeloid leukemia (AML), the field of AML therapeutics is rapidly progressing. In this interview, Farhad Ravandi, MD, from the University of Texa... Author: VJHemOnc Added: 08/16/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts